Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Pharma

Unapproved in US for decades, levosimendan stumbles in ph. 3

Despite the flop, Tenax has zeroed in on a prespecified subgroup of patients with greater disease burden and plans to request a meeting with the FDA.

Angus Liu Aug 10, 2026 4:40pm

Fierce Biotech

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Aug 7, 2026 9:08am

‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters

Aug 5, 2026 10:12am

In a first, Otsuka’s Voyxact stabilizes IgAN kidney loss in ph.3

Aug 3, 2026 5:00pm

Fierce Biotech

After 5-month wait, BioNTech reveals Sobi CEO will take top job

Aug 3, 2026 7:35am

Editor’s Corner: Why an AZ-BMS merger would be a very bad idea

Aug 3, 2026 12:25am